Technology | November 29, 2007

Bayer Healthcare Pharmaceuticals responded to concerns by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) on administering contrast agents by previewing at RSNA 2007 VistaTrak, a password protected contrast media cabinet that tracks media stock using RFID labels.

Designed to help meet JCAHO regulations on safety, the cabinet can be interfaced with an electronic medical record (EMR), PACS/RIS and billing system to access patient data and monitor for allergic reactions. The monitoring system is designed to help prevent the potential risk of nephrogenic systemic fibrosis (NSF) when a patient is injected with gadolinium-containing contrast agents for magnetic resonance imaging (MRI). The company’s MAGNEVIST (gadopentetate dimeglumine) contrast agent will be the first product to carry the RFID tag in the VistaTrak cabinet.

The cabinet is also password protected to comply with JCAHO’s requirement for contrast agent cabinets to be kept under lock and key. The cabinet is only accessible by using either a coded badge or a pin code.

Once a bottle is removed, the RFID tag inside of the cabinet reads the lot number, expiration date and other information on the label required by JCAHO. The EMR, PACS/RIS and billing system are updated when a bottle is removed from the cabinet to track the procedure and inventory. VistaTrak will not be commercially available until mid-2008.

November 2007


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now